open access

Vol 17, No 4 (2012)
Published online: 2012-07-01
Submitted: 2011-08-04
Get Citation

Adyuvant fractionated radiotherapy after resection of intracranial hemangiopericytoma

Cristina Prado, Arturo Navarro-Martin, Ana Lucas, Miquel Macià, Ferran Guedea
DOI: 10.1016/j.rpor.2012.03.005
·
Rep Pract Oncol Radiother 2012;17(4):237-242.

open access

Vol 17, No 4 (2012)
Published online: 2012-07-01
Submitted: 2011-08-04

Abstract

Aim

Review of literature and adjuvant treatment in Hemangiopericytoma after complete resection.

Background

Intracranial hemangiopericytoma (HPC) is an uncommon malignant vascular tumor arising from mesenchymal cells with pericytic differentiation. Surgery remains the mainstay treatment, and adjuvant radiation therapy appears to be appropriate for patients with high grade tumors or incomplete resection. We present our experience and review of the literature.

Materials and methods

We describe two cases of intracranial hemangiopericytoma located in the frontal lobe of the CNS. Both patients underwent complete tumor resection followed by adjuvant fractionated radiotherapy and completed treatment without interruptions.

Results

A local recurrence was observed in one of these cases and fractionated stereotactic radiotherapy was performed. Both patients are alive and disease has been under control up to date.

Conclusion

The treatment of choice for intracranial hemangiopericytoma is a complete surgical resection as long as possible. Adjuvant radiotherapy of HPC can result in increased tumor control and should be considered as an effective treatment for patients with high grade or demonstrated residual tumor in the postoperative period. Salvage treatment using limited-field fractionated radiotherapy for local recurrence treatment is considered an acceptable option.

Abstract

Aim

Review of literature and adjuvant treatment in Hemangiopericytoma after complete resection.

Background

Intracranial hemangiopericytoma (HPC) is an uncommon malignant vascular tumor arising from mesenchymal cells with pericytic differentiation. Surgery remains the mainstay treatment, and adjuvant radiation therapy appears to be appropriate for patients with high grade tumors or incomplete resection. We present our experience and review of the literature.

Materials and methods

We describe two cases of intracranial hemangiopericytoma located in the frontal lobe of the CNS. Both patients underwent complete tumor resection followed by adjuvant fractionated radiotherapy and completed treatment without interruptions.

Results

A local recurrence was observed in one of these cases and fractionated stereotactic radiotherapy was performed. Both patients are alive and disease has been under control up to date.

Conclusion

The treatment of choice for intracranial hemangiopericytoma is a complete surgical resection as long as possible. Adjuvant radiotherapy of HPC can result in increased tumor control and should be considered as an effective treatment for patients with high grade or demonstrated residual tumor in the postoperative period. Salvage treatment using limited-field fractionated radiotherapy for local recurrence treatment is considered an acceptable option.

Get Citation

Keywords

Hemangiopericytoma; Radiotherapy; Fractionated radiotherapy; Stereotactic radiosurgery

About this article
Title

Adyuvant fractionated radiotherapy after resection of intracranial hemangiopericytoma

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 17, No 4 (2012)

Pages

237-242

Published online

2012-07-01

DOI

10.1016/j.rpor.2012.03.005

Bibliographic record

Rep Pract Oncol Radiother 2012;17(4):237-242.

Keywords

Hemangiopericytoma
Radiotherapy
Fractionated radiotherapy
Stereotactic radiosurgery

Authors

Cristina Prado
Arturo Navarro-Martin
Ana Lucas
Miquel Macià
Ferran Guedea

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl